Table 3.
Secondary Outcomes Among Participants in the Severe Category
| Severe A | Severe B | Severe C | P-value (Intergroups) | ||||
|---|---|---|---|---|---|---|---|
| Number | % | Number | % | Number | % | ||
| Number of deaths during the study period | |||||||
| All-cause mortality | 6/21 | 28.57 | 3/20 | 15 | 5/22 | 22.72 | >0.05 |
| Increase in oxygen requirement on 1st follow-up (at 72 hours) | 15/21 | 71.42 | 17/20 | 85 | 18/21 | 85.71 | >0.05 |
| Increase in oxygen requirement on 2nd follow-up (at 144 hours) | 6/11 | 54.54 | 9/13 | 69.23 | 9/12 | 75 | >0.05 |
| Requirement of non-invasive ventilation (NIV) | |||||||
| NIV on 1st follow-up (at 72 hours) | 5/21 | 23.8 | 2/20 | 10 | 5/21 | 23.8 | >0.05 |
| NIV on 2nd follow-up (144 hours) | 3/9 | 33.33 | 1/11 | 9.09 | 1/6 | 16.66 | >0.05 |
| Requirement of mechanical ventilation (MV) | |||||||
| MV on 1st follow-up (at 72 hours) | 2/21 | 9.52 | 1/20 | 5 | 5/21 | 23.8 | >0.05 |
| MV on 2nd follow-up (144 hours) | 3/11 | 27.27 | 1/13 | 7.69 | 1/12 | 8.33 | >0.05 |
| Mean duration of hospital stays | 14.08 days (SD=11.35) | 14.15 days (SD=6.08) | 14.42 days (SD=13.27) | >0.05 | |||
Notes: Participants who are already on NIV/MV at the time of allocation were excluded in determining the proportion.
Abbreviation: SD, standard deviation.